These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 13678396)

  • 1. Case reports illustrate consequences of ATP III in practice.
    Schuster H
    Am J Manag Care; 2003 Aug; Suppl():5-6. PubMed ID: 13678396
    [No Abstract]   [Full Text] [Related]  

  • 2. National Cholesterol Education Panel III guidelines performance role in preventing myocardial infarction in a large cohort without a history of coronary artery disease: Korea Acute Myocardial Infarction Registry study.
    Yoon YE; Rivera JJ; Kwon DA; Chae IH; Jeong MH; Rha SW; Blumenthal RS; Nasir K; Chang HJ;
    Prev Cardiol; 2009; 12(2):109-13. PubMed ID: 19476585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cholesterol levels are underevaluated and undertreated.
    Danias PG; O'Mahony S; Radford MJ; Korman L; Silverman DI
    Am J Cardiol; 1998 Jun; 81(11):1353-6. PubMed ID: 9631975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines.
    Clearfield M; Downs JR; Lee M; Langendorfer A; McConathy W; Gotto AM
    Am J Cardiol; 2005 Dec; 96(12):1674-80. PubMed ID: 16360356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid management with statins. The lower the better?
    Laufs U; Liao JK; Böhm M
    Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence of the efficacy of hypocholesterolemic treatment in primary and secondary prevention of ischemic heart disease].
    Alvarez-Sala Walther LA; Millán Núñez-Cortés J
    Med Clin (Barc); 2000; 114 Suppl 2():1-10. PubMed ID: 10916798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
    Davidson MH; Maki KC; Pearson TA; Pasternak RC; Deedwania PC; McKenney JM; Fonarow GC; Maron DJ; Ansell BJ; Clark LT; Ballantyne CM
    Am J Cardiol; 2005 Aug; 96(4):556-63. PubMed ID: 16098311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of myocardial infarction attributable to elevated levels of total cholesterol among hypertensives.
    Glazer NL; Smith NL; Heckbert SR; Doggen CJ; Lemaitre RN; Psaty BM
    Am J Hypertens; 2005 Jun; 18(6):759-66. PubMed ID: 15925732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The "healthy" patient with hypercholesterolemia].
    Klose G
    Med Klin (Munich); 2005 Feb; 100(2):99-106; quiz 107-8. PubMed ID: 15711905
    [No Abstract]   [Full Text] [Related]  

  • 12. New guidelines on high cholesterol.
    Sherman FT
    Geriatrics; 2001 Jul; 56(7):3-4. PubMed ID: 11490984
    [No Abstract]   [Full Text] [Related]  

  • 13. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 14. [New studies of high dosage statins and fibrates. How is lipid lowering therapy changing? (interview by Dr. med. Dirk Einecke)].
    Klose G
    MMW Fortschr Med; 2005 Dec; 147(49-50):20. PubMed ID: 16401005
    [No Abstract]   [Full Text] [Related]  

  • 15. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts].
    MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart lines. Revised cholesterol guidelines.
    Harv Heart Lett; 2001 Jul; 11(11):6-7. PubMed ID: 11512536
    [No Abstract]   [Full Text] [Related]  

  • 17. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.
    Cullen MW; Stein JH; Gangnon R; McBride PE; Keevil JG
    Am Heart J; 2008 Aug; 156(2):284-91. PubMed ID: 18657658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
    Rosenson R; Lloyd-Jones D;
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Summary of the 'Cholesterol' guideline (first revision) of the Dutch College of Family Practice].
    Bonneux L
    Ned Tijdschr Geneeskd; 2000 Apr; 144(18):862-3. PubMed ID: 10816777
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan.
    Nagata-Kobayashi S; Shimbo T; Matsui K; Fukui T
    Int J Cardiol; 2005 Sep; 104(2):213-23. PubMed ID: 16168816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.